Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

References for PMC Articles for PubMed (Select 17909053)

1.

Neuroblastoma.

Maris JM, Hogarty MD, Bagatell R, Cohn SL.

Lancet. 2007 Jun 23;369(9579):2106-20. Review.

PMID:
17586306
2.

Childhood tumors of the nervous system as disorders of normal development.

Grimmer MR, Weiss WA.

Curr Opin Pediatr. 2006 Dec;18(6):634-8. Review.

PMID:
17099362
3.

Methionine aminopeptidase 2 inhibition is an effective treatment strategy for neuroblastoma in preclinical models.

Morowitz MJ, Barr R, Wang Q, King R, Rhodin N, Pawel B, Zhao H, Erickson SA, Sheppard GS, Wang J, Maris JM, Shusterman S.

Clin Cancer Res. 2005 Apr 1;11(7):2680-5.

4.

Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin.

Satchi-Fainaro R, Mamluk R, Wang L, Short SM, Nagy JA, Feng D, Dvorak AM, Dvorak HF, Puder M, Mukhopadhyay D, Folkman J.

Cancer Cell. 2005 Mar;7(3):251-61.

5.

Antiangiogenic strategies in neuroblastoma.

Ribatti D, Ponzoni M.

Cancer Treat Rev. 2005 Feb;31(1):27-34. Epub 2004 Nov 18. Review.

PMID:
15707702
6.

Angiogenesis in neuroblastoma.

Ribatti D, Marimpietri D, Pastorino F, Brignole C, Nico B, Vacca A, Ponzoni M.

Ann N Y Acad Sci. 2004 Dec;1028:133-42. Review.

PMID:
15650239
7.

High activin A-expression in human neuroblastoma: suppression of malignant potential and correlation with favourable clinical outcome.

Schramm A, von Schuetz V, Christiansen H, Havers W, Papoutsi M, Wilting J, Schweigerer L.

Oncogene. 2005 Jan 20;24(4):680-7.

PMID:
15580313
8.

Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification.

Hansford LM, Thomas WD, Keating JM, Burkhart CA, Peaston AE, Norris MD, Haber M, Armati PJ, Weiss WA, Marshall GM.

Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12664-9. Epub 2004 Aug 16.

9.

Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment.

Chantrain CF, Shimada H, Jodele S, Groshen S, Ye W, Shalinsky DR, Werb Z, Coussens LM, DeClerck YA.

Cancer Res. 2004 Mar 1;64(5):1675-86.

10.

Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470.

Satchi-Fainaro R, Puder M, Davies JW, Tran HT, Sampson DA, Greene AK, Corfas G, Folkman J.

Nat Med. 2004 Mar;10(3):255-61. Epub 2004 Feb 22.

11.

Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors.

Hackett CS, Hodgson JG, Law ME, Fridlyand J, Osoegawa K, de Jong PJ, Nowak NJ, Pinkel D, Albertson DG, Jain A, Jenkins R, Gray JW, Weiss WA.

Cancer Res. 2003 Sep 1;63(17):5266-73.

12.

Fenretinide as an anti-angiogenic agent in neuroblastoma.

Ribatti D, Raffaghello L, Marimpietri D, Cosimo E, Montaldo PG, Nico B, Vacca A, Ponzoni M.

Cancer Lett. 2003 Jul 18;197(1-2):181-4. Review.

PMID:
12880979
13.

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.

Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D.

J Clin Invest. 2003 May;111(9):1287-95.

14.

Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis.

Watnick RS, Cheng YN, Rangarajan A, Ince TA, Weinberg RA.

Cancer Cell. 2003 Mar;3(3):219-31. Retraction in: Cancer Cell. 2013 Jan 14;23(1):129.

PMID:
12676581
15.

VEGF receptors are differentially expressed by neuroblastoma cells in culture.

Beierle EA, Dai W, Langham MR Jr, Copeland EM 3rd, Chen MK.

J Pediatr Surg. 2003 Mar;38(3):514-21.

PMID:
12632379
16.

In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression.

Ribatti D, Raffaghello L, Pastorino F, Nico B, Brignole C, Vacca A, Ponzoni M.

Int J Cancer. 2002 Dec 1;102(4):351-4.

PMID:
12402304
17.

Effects of recombinant human endostatin on a human neuroblastoma xenograft.

Kuroiwa M, Ikeda H, Hongo T, Tsuchida Y, Hirato J, Kaneko Y, Suzuki N, Obana K, Makino SI.

Int J Mol Med. 2001 Oct;8(4):391-6.

PMID:
11562777
18.

Antiangiogenic therapy inhibits human neuroblastoma growth.

Katzenstein HM, Salwen HR, Nguyen NN, Meitar D, Cohn SL.

Med Pediatr Oncol. 2001 Jan;36(1):190-3.

PMID:
11464880
19.

The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease.

Shusterman S, Grupp SA, Barr R, Carpentieri D, Zhao H, Maris JM.

Clin Cancer Res. 2001 Apr;7(4):977-84.

20.

Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with progression in human neuroblastoma.

Ribatti D, Surico G, Vacca A, De Leonardis F, Lastilla G, Montaldo PG, Rigillo N, Ponzoni M.

Life Sci. 2001 Jan 26;68(10):1161-8.

PMID:
11228100
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk